Advancements in next-generation sequencing have greatly enhanced the development of
biomarker-driven cancer therapies. The affordability and availability of next-generation …

Opinion statement Effective therapy for treatment of colorectal cancer includes
comprehensive and evidence-based therapies that may include a combination of surgery …

Background Financial toxicity includes distress and burden from cancer‐related costs.
Women are more likely to experience worse cancer‐related financial outcomes than men …

Objectives: To describe financial toxicity (FT) in patients with resected lung cancer and
identify risk factors in this population. Background: FT describes the financial burden …

Background Cancer-related financial hardship can negatively impact financial well-being
and may prevent adolescent and young adult (AYA) cancer survivors (ages 15–39) from …

Background Based on previous reports of disparities in financial burden following a cancer
diagnosis, this study aims to characterize mechanisms of disparities experienced by …

Objective To evaluate disparities in financial toxicity and psychological distress in patients
with cancer as a function of treatment and reveal the relationship between financial toxicity …

Introduction Financial toxicity is common and pervasive among cancer patients. Research
suggests that gynecologic cancer patients experiencing financial toxicity are at increased …

Background Financial toxicity contributes to psychosocial distress among cancer patients
and survivors. Yet, contextual factors unique to rural settings affect patient experiences, and …

BACKGROUND: Cancer therapy is associated with severe financial burden. However, the
magnitude and longitudinal patient relationship with financial toxicity (FT) in the initial course …